LGDA and our partners LGD Alliance Europe and the Lymphatic Malformations Institute share resources and efforts to rise funds for LM/CLA research. This research has a direct impact on the care of patients and our understanding of these diseases.
-
Now Open and accepting LOIs. Deadline is March 20, 2026.
Pilot awards are intended to test new hypotheses or technologies that have the potential to significantly advance our understanding and/or treatment of CCLA, GLA, GSD, or KLA.
-
This award is made possible by the LGDA, LGD Alliance Europe (UK), LGD Alliance Europe, and the LMI.
-
These grants received matching funds through the Orphan Disease Center. Current fundraising efforts support the Alfie Milne Young Investigator Award.
